Neuropsychological deficits associated with antiphospholipid antibodies

Journal of Clinical and Experimental Neuropsychology

Volumn 21, Issue 2, 1999, Pages 251-264

  Jacobson, Mark W ^a,b   Rapport, Lisa J ^b,e   Keenan, Pamela A ^c   Coleman, Renee D ^b   Tietjen, Gretchen E ^d  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d MEDICAL COLLEGE OF OHIO   (United States)

^e Marygrove College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; LEARNING; MALE; MEMORY; MENTAL FUNCTION; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK;

ANTIBODIES, ANTIPHOSPHOLIPID; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; COGNITION DISORDERS; DECISION MAKING; DEMENTIA, VASCULAR; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; MOTOR SKILLS; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; VERBAL LEARNING;

EID: 0032856571     PISSN: 13803395     EISSN: None     Source Type: Journal    
DOI: 10.1076/jcen.21.2.251.931     Document Type: Article

References (60)

1. Albert, M.S. (1996). Cognitive and neurobiologic markers of early Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 93, 13547-13551.
2. Aharon-Peretz, J., Brenner, B., Amyel-Zvi, E., Metz, L., & Hemlik, J. (1996). Neurocognitive dysfunction in the antiphospholipid antibody syndrome (APS). Neuropsychiatry, Neuropsychology, & Behavioral Neurology, 9, 123-126.
3. Asherson, R.A. (1991) "Primary" antiphospholipid antibody syndrome. In E.N. Harris, T. Exner, G.R.V. Hughes, & R.A. Asherson (Eds.), Phospholipid-Binding Antibodies (pp. 378-386). Boca Raton, LA: CRC Press.
4. Asherson R.A., Mercy, D., & Phillips, G. (1987). Recurrent stroke and multi-infarct dementia in SLE associated with antiphospholipid antibodies. Annals of Rheumatologic Disease, 46, 605-611.
5. Beck, A.T. (1987). Beck Depression Inventory: Manual. San Antonio: Psychological Corporation.
6. Benton, A.L., & Hamsher, K. (1976). Multilingual Aphasia Examination. Iowa City, IA: University of Iowa.
7. Briley, D.P., Coull, B.M., & Goodnight, S.H., (1989). Neurologic disease associated with antiphospholipid antibodies. Annals of Neurology, 25, 221-227.
8. Carreras, L.O., & Vernylen, J.G. (1982). Lupus anticoagulant and thrombosis: Possible role of inhibition of prostacyclin formation. Thrombosis Haemostas, 48, 38-40.
9. Chengappa, K.N.R., Carpenter, A.B., & Keshavan, M.S. (1991). Elevated IgG and IgM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients. Biological Psychiatry, 30, 731-735.
10. Cohen, A.J., Phillips, T.M., & Kessler, C. M. (1986). Circulating coagulation inhibitors in the acquired immunodeficiency syndrome. Annals of Internal Medicine, 104, 175-180.
11. Coull B.M., Bourdette D., Goodnight S.H., Briley D.P., & Hart, R. (1987). Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke, 18, 1107-1112.
12. Coull, B.M., & Goodnight, S.H. (1990). Antiphospholipid antibodies, prethrombotic states, and stroke. Stroke, 21, 1370-1374.
13. Cummings, J., & Benson, F. (1990). Subcortical mechanisms and human thought. In J. Cummings (Ed.), Subcortical Dementia (pp. 251-260). New York: Oxford University Press.
14. Czlonkowska, A., Meurer, M., Palasik, W., Baranska-Gierusczcak, M., Mendel T., & Wierzchowska, E. (1992). Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger population. Acta Neurologica Scandinavica, 86, 304-307.
15. Delis, D., Filoteo, J., Massman, P., Kaplan, E., & Kramer, J. (1994). The clinical assessment of memory disorders. In L. Cermak, (Ed.), Neuropsychological Explorations of Memory and Cognition: Essays in Honor of Nelson Butters (pp. 223 - 239). New York: Plenum Press.
16. Delis, D.C., Kramer, J., Kaplan, E., & Ober, B. (1987). The California Verbal Learning Test. San Antonio, TX: Harcourt, Brace, Jovanovich.
17. Denburg, S. D., Carbotte, R.M., Ginsberg, J.S., & Denburg, J.A. (1997) The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. Journal of the International Neuropsychological Society, 3, 377-386.
18. Digre, K.B., Durcan, F.J., Branch D.W., Jacobson, D.M., Varner, M.W., & Baringer, J.R. (1989). Amaurosis fugax associated with antiphospholipid antibodies. Annals of Neurology, 25, 228-232.
19. Dull-Baird, A., Adams, K., Shatz, M., Brown, G., Diaz, F., Ausman, J. (1984). Can neuropsychological tests detect the sites of cerebrovascular stenoses and occlusions? Neurosurgery, 14, 416-423.
20. Filoteo, J.V., Delis, D.C., Demadura, T., Salmon, D., Roman, M., & Shults, C. (1994). Abnormally rapid disengagement of covert attention to global and local stimulus levels may underlie the visuoperceptual impairment in Parkinson's patients. Neuropsychology, 8, 210-217.
21. Freyssinet J.M., & Cazenave J.P.(1989). Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis. Thrombos Haemostas 61, 175-177.
22. Gorman, D., & Cummings, J. (1993). Neurobehavioral presentations of the antiphospholipid antibody syndrome. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 37-42.
23. Harris E.N., Asherson, R.A., & Hughes G.R.V. (1988). Antiphospholipid antibodies: Autoantibodies with a difference. Annual Review of Medicine, 39, 261-271.
24. Harris, E.N., Gharavi A.E., Hughes G.R.V. (1985). Antiphospholipid antibodies. Clinical Rheumatic Disease, 11, 591-609.
25. Heaton, R.K. (1981). Wisconsin Card Sorting Test Manual. Odessa, FL: Psychological Assessment Resources.
26. Heaton, R.K., Grant, I., & Matthews, C.G. (1991). Comprehensive Norms for An Expanded Halstead-Reitan Neuropsychological Test Battery. Odessa, FL: Psychological Assessment Resources.
27. Hess D.C., Krauss J., Adams R.J., Nichols F.T., Ahang D., & Rountree H.A. (1990). Anticardiolipin antibodies: A study of frequency in TIA and stroke. Neurology, 41, 525-528.
28. Hughes, G. (1993). The antiphospholipid syndrome: Ten years on. Lancet, 342, 341-344.
29. Jacobson, M.W., Abraham, E., & Tietjen, G. (1996). A review of neurological sequelae and cognitive deficits associated with antiphospholipid antibodies. Journal of Stroke and Cerebrovascular Diseases, 6, 61-66.
30. Khamashta, M.A., Harris, E.N., Gharavi, A.E., Derue G., Gil, A., Vazquez, J.J., & Hughes G.R.V. Immune mediated mechanisms for thrombosis: Antiphospholipid antibody binding to platelet membranes. Annals of Rheumatic Disease, 47, 849-854.
31. Kurita, A., Hasunuma, T., Mochio, S., Shimada, T., Yukihide, I., & Kurahasi, T. (1994). A young case with multi-infarct dementia associated with lupus anticoagulant. Internal Medicine, 33, 373-376.
32. Levine, Steven R. (1997). Antiphospholipid antibody syndrome. In K.M.A. Welch, L.R. Caplan, D.J. Reis, B.K. Siesjo, & B. Weir (Eds.), Primer on Cerebrovascular Diseases (pp. 381-384). San Diego, CA: Academic Press.
33. Levine, S.R., Deegan, M.J., Futrell, N., & Welch, K.M.. (1990). Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 Cases. Neurology, 40, 1181-1189.
34. Levine, S. R., Welch, K.M.A. (1987). The spectrum of neurological disease associated with antiphospholipid antibodies: Lupus anticoagulants and anticardiolipin antibodies. Archives of Neurology, 543, 876-883.
35. Lockshin, M.D. (1992). Antiphospholipid antibody syndrome. Journal of the American Medical Association, 268, 1451-1453.
36. Love, P.E., & Santoro, S.A. (1990). Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and non-SLE Disorders. Annals of Internal Medicine, 112, 682-698.
37. Maes, M., Meltzer, H., Jacobs, J., Suy, E., Calabrese, J., Minner, B., & Rause, J. (1993). Autoimmunity in depression: Increased antiphospholipid autoantibodies. Acta Psychiatrica Scandinavica, 87, 160-166.
38. Maeshima, E., Yoichi, Y., Susumu, Y., & Nomoto, H. (1992). Higher cortical dysfunction, antiphospholipid antibodies and neuroradiological examinations in systemic lupus erythematosus. Internal Medicine, 31, 1169-1174.
39. Matthy, F., Walshe, K., Mackie, I.J., & Machin S.J. (1989). Familial occurrence of the antiphospholipid syndrome. Journal of Clinical Pathology, 42, 495-497.
40. Montalban, J., Codina, A., Ordi, J., Vilardell, M., Khamashta M., & Hughes, G.R.V. (1991). Antiphospholipid antibodies in cerebral ischemia. Stroke, 22, 750-753.
41. Nencini P., Baruffi, M.C., Abbate, R., Massai, G., Amaducci, L., & Inzitari, D. (1992). Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke, 23, 189-193.
42. Parasuraman, R., Greenwood, P.M., Haxby, J.V. & Grady, C.L. (1992). Visuospatial attention in dementia of the Alzheimer's type. Brain, 115, 711-733.
43. Paulsen, J., Butters, N., Sadek, J., Johnson, B., Salmon, D., Swerdlow, N., Swenson, M. (1995). Distinct cognitive profiles of cortical and subcortical dementia in advanced illness. Neurology, 45, 951-956.
44. Peavy, G., Jacobs, D., Salmon, D., Butters, N., Delis, C., Taylor, M., Massman, P., Stout J.C., Heindel, W., Kirson, D., & HRNC Group. (1994). Verbal memory performance of patients with human immunodeficiency virus infection: Evidence of sub-cortical dysfunction. Journal of Clinical and Experimental Neuropsychology, 16, 508-523.
45. Provenzale, J.M., Barboriak, D.P., Allen, N.B., & Ortel, T.L. (1996). Patients with antiphospholipid antibodies: CT and MR findings of the brain. American Journal of Roentgenology, 167, 1573-1578.
46. Reitan, R.M. (1969). Manual for Administration of Neuropsychological Test Batteries for Adults and Children. Tucson, AZ: Neuropsychology Press.
47. Reitan, R.M., & Wolfson, D. (1985). The Halstead-Reitan Neuropsychological Test Battery. Tucson, AZ: Neuropsychology Press.
48. Rey, A. (1941). L'examen psychologique dans les cas d'encephalopathie tramatique. Archives de Psychologie, 30, 286-356.
49. Schmidt, R., Auer-Grumbach, P., Fazekas, F., Offenbacher, H., & Kapeller, P. (1995). Anticardiolipin antibodies in normal subjects: Neuropsychological correlates and MRI findings. Stroke, 26, 749-754.
50. Spielberger, C.D. (1985). Assessment of state and trait anxiety: Conceptual and methodological issues. Southern Psychologist, 2, 6-16.
51. Spreen, O., & Benton, A.L. (1977). Neurosensory Center Comprehensive Examination for Aphasia. Victoria: University of Victoria.
52. Stevens, J. (1992). Applied Multivariate Statistics for the Social Sciences (2nd Ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
53. The Antiphospholipid Antibodies in Stroke Study Group. (1990). Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke, 21, 1268-1273.
54. Tietjen, G.E. (1992). Migraine and antiphospholipid antibodies. Cephalalgia, 12, 70-74.
55. Tietjen, G.E., Day, M., Norris, L., Aurora, S., Halvorsen, A., Schultz, L.R., & Levine, S.R. (1998). Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events. A prospective study. Neurology, 50, 1433-1440.
56. Rosove, M., & Brewer, P.M.C. (1992). Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients. Annals of Internal Medicine, 117, 303-308.
57. Toren, P., Toren, A., Weizman, A., Mozes, T., Eldar, S., Magor, A., Mandel, M., Rechavi, G., Many, A., & Mester, R. (1994). Tourette's Disorder: Is there an association with the antiphospholipid syndrome? Biological Psychiatry, 35, 495-498.
58. Wechsler, D. (1981). Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corporation.
59. Wechsler, D. (1987). Wechsler Memory Scale - Revised. New York: The Psychological Corporation.
60. Ziporen, L., Korczyn, A.D., Polak, S., Golberg, I., & Schoenfeld, Y. (1998). Neurological dysfunction associated with antiphospholipid antibody syndrome: Histopathological findings of thrombotic vasculopathy in a mouse model. Annals of Neurology, 44, 486A.